Lunsumio in combination with lenalidomide may offer an effective treatment in relapsed or refractory follicular lymphoma based on first data from single-arm cohort of Phase III CELESTIMO study –– Data ...

The National Defense Authorization Act is steaming toward passage. But buried within the massive 3,000 page document, there ...

A doctor in the US who found asbestos in his son's sandpit tried in vain to get stronger regulations. Almost 40 years later ...

Tesla’s ($TSLA) stock has started showing signs of life again, bouncing back after months of pressure from soft deliveries, rising EV competition, ...

SSM Health St. Agnes Hospital has been recognized by Becker’s Hospital Review for not having any cases of catheter-associated ...

KT-621 achieved deep STAT6 degradation across both the 100 mg and 200 mg dose groups tested, with median reductions of 94% and 98% in skin and blood, respectively, demonstrating strong translation ...

Companies are rapidly making AI use an expectation for employees, but the shift brings new challenges for EHS professionals ...

Why in-line monitoring is the missing link in bioenergy efficiency. By Sarah Hammond Biomass has emerged as a powerful ...

While Breaking Bad is undoubtedly one of the great crime dramas of recent TV history, it also has its share of cringey, often ...

Two recent Campylobacter outbreaks traced to poultry meat in Denmark highlight the issues with current regulations, according ...

Although 2025 isn't technically over yet, most of whatever was going to happen to, for, or with a stock has already happened.

HYMPAVZI is currently approved in more than 40 countries for the treatment of eligible patients 12 years of age and older living with hemophilia A without factor VIII inhibitors, or hemophilia B ...